vs
Arlo Technologies, Inc.（ARLO）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是Arlo Technologies, Inc.的1.5倍（$207.3M vs $141.3M），Arlo Technologies, Inc.净利率更高（4.1% vs -62.0%，领先66.1%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs 16.2%），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 6.7%）
Arlo Technologies是一家专注于无线监控摄像头研发生产的美国企业。在2018年8月于纽交所完成首次公开募股之前，Arlo一直是网件（Netgear）旗下的监控产品品牌，IPO之后网件仍持有该公司多数控制权。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ARLO vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $141.3M | $207.3M |
| 净利润 | $5.8M | $-128.6M |
| 毛利率 | 46.4% | — |
| 营业利润率 | 3.3% | -54.7% |
| 净利率 | 4.1% | -62.0% |
| 营收同比 | 16.2% | 25.9% |
| 净利润同比 | 218.6% | 3.5% |
| 每股收益（稀释后） | $0.06 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $141.3M | $207.3M | ||
| Q3 25 | $139.5M | $159.9M | ||
| Q2 25 | $129.4M | $166.5M | ||
| Q1 25 | $119.1M | $139.3M | ||
| Q4 24 | $121.6M | $164.6M | ||
| Q3 24 | $137.7M | $139.5M | ||
| Q2 24 | $127.4M | $147.0M | ||
| Q1 24 | $124.2M | $108.8M |
| Q4 25 | $5.8M | $-128.6M | ||
| Q3 25 | $6.9M | $-180.4M | ||
| Q2 25 | $3.1M | $-115.0M | ||
| Q1 25 | $-835.0K | $-151.1M | ||
| Q4 24 | $-4.9M | $-133.2M | ||
| Q3 24 | $-4.4M | $-133.5M | ||
| Q2 24 | $-11.6M | $-131.6M | ||
| Q1 24 | $-9.6M | $-170.7M |
| Q4 25 | 46.4% | — | ||
| Q3 25 | 40.5% | — | ||
| Q2 25 | 44.9% | — | ||
| Q1 25 | 44.3% | — | ||
| Q4 24 | 36.9% | — | ||
| Q3 24 | 35.2% | — | ||
| Q2 24 | 36.8% | — | ||
| Q1 24 | 38.1% | — |
| Q4 25 | 3.3% | -54.7% | ||
| Q3 25 | 0.6% | -106.9% | ||
| Q2 25 | 1.5% | -64.8% | ||
| Q1 25 | -1.2% | -102.6% | ||
| Q4 24 | -5.0% | -74.3% | ||
| Q3 24 | -4.0% | -94.6% | ||
| Q2 24 | -10.0% | -79.1% | ||
| Q1 24 | -8.5% | -151.9% |
| Q4 25 | 4.1% | -62.0% | ||
| Q3 25 | 4.9% | -112.8% | ||
| Q2 25 | 2.4% | -69.0% | ||
| Q1 25 | -0.7% | -108.5% | ||
| Q4 24 | -4.0% | -80.9% | ||
| Q3 24 | -3.2% | -95.7% | ||
| Q2 24 | -9.1% | -89.5% | ||
| Q1 24 | -7.8% | -156.8% |
| Q4 25 | $0.06 | $-1.28 | ||
| Q3 25 | $0.06 | $-1.81 | ||
| Q2 25 | $0.03 | $-1.17 | ||
| Q1 25 | $-0.01 | $-1.57 | ||
| Q4 24 | $-0.05 | $-1.34 | ||
| Q3 24 | $-0.04 | $-1.40 | ||
| Q2 24 | $-0.12 | $-1.52 | ||
| Q1 24 | $-0.10 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.4M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $127.8M | $-80.0M |
| 总资产 | $310.5M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $146.4M | $421.0M | ||
| Q3 25 | $86.0M | $202.5M | ||
| Q2 25 | $71.2M | $176.3M | ||
| Q1 25 | $84.0M | $127.1M | ||
| Q4 24 | $82.0M | $174.0M | ||
| Q3 24 | $77.0M | $150.6M | ||
| Q2 24 | $62.9M | $480.7M | ||
| Q1 24 | $62.1M | $112.3M |
| Q4 25 | $127.8M | $-80.0M | ||
| Q3 25 | $129.2M | $9.2M | ||
| Q2 25 | $118.3M | $151.3M | ||
| Q1 25 | $103.4M | $144.2M | ||
| Q4 24 | $100.9M | $255.0M | ||
| Q3 24 | $96.9M | $346.8M | ||
| Q2 24 | $99.3M | $432.4M | ||
| Q1 24 | $99.9M | $140.3M |
| Q4 25 | $310.5M | $1.5B | ||
| Q3 25 | $350.9M | $1.2B | ||
| Q2 25 | $319.7M | $1.3B | ||
| Q1 25 | $296.6M | $1.3B | ||
| Q4 24 | $298.4M | $1.5B | ||
| Q3 24 | $312.4M | $1.5B | ||
| Q2 24 | $295.8M | $1.6B | ||
| Q1 24 | $289.8M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.8M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-100.8M |
| 自由现金流率自由现金流/营收 | — | -48.6% |
| 资本支出强度资本支出/营收 | — | 0.5% |
| 现金转化率经营现金流/净利润 | 3.43× | — |
| 过去12个月自由现金流最近4个季度 | — | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $19.8M | $-99.8M | ||
| Q3 25 | $19.2M | $-91.4M | ||
| Q2 25 | $8.8M | $-108.3M | ||
| Q1 25 | $30.9M | $-166.5M | ||
| Q4 24 | $6.7M | $-79.3M | ||
| Q3 24 | $18.4M | $-67.0M | ||
| Q2 24 | $6.5M | $-77.0M | ||
| Q1 24 | $19.8M | $-190.7M |
| Q4 25 | — | $-100.8M | ||
| Q3 25 | — | $-92.7M | ||
| Q2 25 | — | $-110.7M | ||
| Q1 25 | $28.1M | $-167.8M | ||
| Q4 24 | $5.6M | $-79.5M | ||
| Q3 24 | $17.4M | $-68.6M | ||
| Q2 24 | $6.2M | $-79.0M | ||
| Q1 24 | $19.4M | $-193.9M |
| Q4 25 | — | -48.6% | ||
| Q3 25 | — | -58.0% | ||
| Q2 25 | — | -66.5% | ||
| Q1 25 | 23.6% | -120.5% | ||
| Q4 24 | 4.6% | -48.3% | ||
| Q3 24 | 12.6% | -49.2% | ||
| Q2 24 | 4.8% | -53.7% | ||
| Q1 24 | 15.7% | -178.2% |
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | 2.4% | 1.0% | ||
| Q4 24 | 0.9% | 0.1% | ||
| Q3 24 | 0.7% | 1.2% | ||
| Q2 24 | 0.2% | 1.4% | ||
| Q1 24 | 0.3% | 3.0% |
| Q4 25 | 3.43× | — | ||
| Q3 25 | 2.79× | — | ||
| Q2 25 | 2.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARLO
| Subscriptions And Services | $89.4M | 63% |
| Products | $51.9M | 37% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
